Spring 2016 Vol. 06 Issue 01
-
From the Editor-in-Chief
Cancer Research: Back to the BasicsMore basic research is needed to understand how various alterations in genes lead to cancers.
by William G. Nelson, MD, PhD
-
Editor's Letter
Shoot for the MoonHow can Vice President Joe Biden's "Moonshot" initiative make true progress against cancer?
by Kevin McLaughlin
-
Your Cancer Guide
Contemplating CAMComplementary and alternative medicine (CAM) can supplement, but not replace, established cancer treatments.
by Hester Hill Schnipper
-
Caregiving With Confidence
When Roles ChangeFollow these tips for keeping your sense of self despite a shift in responsibilities.
by Carly O'Brien
-
Practical Pointers
Do You Have Questions for Your Health Care Team?Make the most of email, text messages, Twitter and patient portals.
by Ide Mills
-
The High-Deductible Gamble
High-deductible health insurance plans can leave cancer patients scrambling to pay the bills for tests and treatments.
by Charlotte Huff
-
The Power of 1
Studies focused on individuals rather than large numbers of people can help some patients while advancing knowledge.
by Stephen Ornes
-
Survivor Profile
Living in the Here and NowA metastatic melanoma survivor is hopeful but realistic as new treatments become available.
by Jenny Song
-
Q&A
Easing Into ActivityCancer exercise specialist and survivor Julie Goodale offers tips for staying active during and after treatment.
by Ronni Gordon
-
Sound Advice
Your Questions, Our AnswersWhen a family member wants to stop treatment, addressing post-treatment anxiety and sadness, and considering a clinical trial.
-
Get Involved
The Gift of a GetawayGive patients and their families a break from cancer.
by Maria Wolf
-
In the Moment- Spring 2016
Colleen Bokor, Dana Stewart, Brittany Avin.
The recently approved immunotherapy Amtagvi uses a patient’s own immune cells to destroy advanced melanoma.
by Sandra Gordon
Dealing With Immediate Medical Test ResultsPatients have been entitled to immediate access to medical records and test results for three years as a result of the Cures Act. It has changed how patients and doctors share information.
by Taneia Surles
Empowering Pediatric Cancer PatientsAfter twice being treated for leukemia as a child, Brady Lucas discusses the mental impact of pediatric cancer.
by Suzanne McBride
Light at the End of the Tunnel for ASPS PatientsImmunotherapy has helped some young people with alveolar soft part sarcoma (ASPS), a rare cancer, but there’s more work to be done.
by Kyle Bagenstose